Returning for a 4th Year... GPCRs-Targeted Drug Discovery!
Transforming the Discovery of Novel GPCR-Targeted Therapies
With positive clinical read outs by Tectonic Therapeutics and recent funding rounds for Confo Therapeutics & Septerna, the potential for novel GPCR drug classes to treat a plethora of diseases grows. Now more than ever, there is a need for the community to come together to share scientific advancements and collaboration opportunities across the full spectrum of GPCR drugs, from small molecules to therapeutic proteins and antibodies.
The 4th GPCRs-Targeted Drug Discovery Summit is returning to Boston (May 20-22, 2025) to showcase the hottest targets of interest, mechanism of action of new GPCR ligands, cutting-edge computational tools to identify high-potential candidates, and effective translational strategies to drive forward discovery & development pipelines to patients in need.
New Topics for 2025 Include:
🧬Novel Modalities Beyond Small Molecules
🧬Successfully Navigating from Discovery to the Clinic
🧬11+ Brand New Organizations Joining the Speaker Faculty including brand new companies like Abalone Bio, Biolexis Therapeutics and Structure Therapeutics speaking for the first time
Join major players in the area of discovering novel therapeutics targeting GPCRs in Boston.
🔗Find out more inside the Agenda: https://ter.li/ve9lcv
🔗Register now: https://ter.li/015rto
